Robert Zackin

2.2k total citations
30 papers, 1.6k citations indexed

About

Robert Zackin is a scholar working on Infectious Diseases, Emergency Medicine and Virology. According to data from OpenAlex, Robert Zackin has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Infectious Diseases, 17 papers in Emergency Medicine and 13 papers in Virology. Recurrent topics in Robert Zackin's work include HIV-related health complications and treatments (17 papers), HIV Research and Treatment (13 papers) and HIV/AIDS Research and Interventions (11 papers). Robert Zackin is often cited by papers focused on HIV-related health complications and treatments (17 papers), HIV Research and Treatment (13 papers) and HIV/AIDS Research and Interventions (11 papers). Robert Zackin collaborates with scholars based in United States, Netherlands and Israel. Robert Zackin's co-authors include Amy C. Justice, Linda Rabeneck, Albert W. Wu, Francesca J. Torriani, W. Keith Henry, Judith A. Aberg, Judith S. Currier, Margaret A. Chesney, Carl J. Fichtenbaum and Susan E. Cohn and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Statistical Association and Annals of Internal Medicine.

In The Last Decade

Robert Zackin

29 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Zackin United States 19 1.1k 948 545 449 153 30 1.6k
Ana Guelar Spain 24 1.2k 1.1× 789 0.8× 542 1.0× 639 1.4× 316 2.1× 48 2.0k
Peter Jensen United States 12 838 0.8× 571 0.6× 515 0.9× 245 0.5× 98 0.6× 14 1.3k
Marianna Menozzi Italy 17 974 0.9× 1.2k 1.3× 498 0.9× 553 1.2× 77 0.5× 46 1.7k
Roger Bedimo United States 26 1.5k 1.4× 1.1k 1.1× 646 1.2× 798 1.8× 354 2.3× 90 2.8k
Joaquín Portilla Spain 23 1.4k 1.2× 564 0.6× 940 1.7× 753 1.7× 156 1.0× 160 2.3k
Colette Smit Netherlands 16 912 0.8× 685 0.7× 360 0.7× 782 1.7× 108 0.7× 49 1.6k
Ferdinand W.N.M. Wit Netherlands 34 2.2k 2.0× 1.5k 1.6× 1.8k 3.3× 1.0k 2.2× 92 0.6× 109 3.6k
Kathleen Melbourne United States 13 898 0.8× 1.1k 1.1× 543 1.0× 180 0.4× 41 0.3× 28 1.5k
Anchalee Avihingsanon Thailand 29 1.7k 1.6× 827 0.9× 852 1.6× 1.5k 3.3× 227 1.5× 206 3.0k
Anna Bonjoch Spain 23 1.3k 1.2× 821 0.9× 973 1.8× 337 0.8× 54 0.4× 63 1.9k

Countries citing papers authored by Robert Zackin

Since Specialization
Citations

This map shows the geographic impact of Robert Zackin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Zackin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Zackin more than expected).

Fields of papers citing papers by Robert Zackin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Zackin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Zackin. The network helps show where Robert Zackin may publish in the future.

Co-authorship network of co-authors of Robert Zackin

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Zackin. A scholar is included among the top collaborators of Robert Zackin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Zackin. Robert Zackin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sattler, Fred R., Natasa Rajicic, Kathleen Mulligan, et al.. (2008). Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss: a randomized, double-blind, multicenter trial. American Journal of Clinical Nutrition. 88(5). 1313–1321. 33 indexed citations
2.
Bosch, Ronald J., Kara Bennett, Ann C. Collier, Robert Zackin, & Constance A. Benson. (2006). Pretreatment Factors Associated With 3-Year (144-Week) Virologic and Immunologic Responses to Potent Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(3). 268–277. 32 indexed citations
3.
Mulligan, Kathleen, Robert Zackin, Jamie H. Von Roenn, et al.. (2006). Testosterone Supplementation of Megestrol Therapy Does Not Enhance Lean Tissue Accrual in Men with Human Immunodeficiency Virus-Associated Weight Loss: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. The Journal of Clinical Endocrinology & Metabolism. 92(2). 563–570. 22 indexed citations
4.
Aberg, Judith A., Robert Zackin, Susan W. Brobst, et al.. (2005). A Randomized Trial of the Efficacy and Safety of Fenofibrate versus Pravastatin in HIV-Infected Subjects with Lipid Abnormalities: AIDS Clinical Trials Group Study 5087. AIDS Research and Human Retroviruses. 21(9). 757–767. 97 indexed citations
5.
Dubé, Michael P., Robert A. Parker, Pablo Tebas, et al.. (2005). Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides. AIDS. 19(16). 1807–1818. 157 indexed citations
6.
Currier, Judith S., Michelle A. Kendall, Robert Zackin, et al.. (2005). Carotid artery intima–media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS. 19(9). 927–933. 143 indexed citations
7.
Wohl, David A., Christopher D. Pilcher, Scott B. Evans, et al.. (2004). Absence of Sustained Hyperlactatemia in HIV-Infected Patients With Risk Factors for Mitochondrial Toxicity. JAIDS Journal of Acquired Immune Deficiency Syndromes. 35(3). 274–278. 14 indexed citations
8.
Goldman, M., Robert Zackin, Carl J. Fichtenbaum, et al.. (2004). Safety of Discontinuation of Maintenance Therapy for Disseminated Histoplasmosis after Immunologic Response to Antiretroviral Therapy. Clinical Infectious Diseases. 38(10). 1485–1489. 87 indexed citations
9.
Shikuma, Cecilia M., Robert Zackin, Fred R. Sattler, et al.. (2004). Changes in Weight and Lean Body Mass during Highly Active Antiretroviral Therapy. Clinical Infectious Diseases. 39(8). 1223–1230. 49 indexed citations
10.
Calabrese, Leonard H., Mary Albrecht, James Young, et al.. (2003). Successful Cardiac Transplantation in an HIV-1–Infected Patient with Advanced Disease. New England Journal of Medicine. 348(23). 2323–2328. 76 indexed citations
11.
Swindells, Susan, Scott Evans, Robert Zackin, et al.. (2002). Predictive Value of HIV-1 Viral Load on Risk for Opportunistic Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes. 30(2). 154–158. 31 indexed citations
12.
Justice, Amy C., Chein‐I Chang, Linda Rabeneck, & Robert Zackin. (2001). Clinical Importance of Provider-Reported HIV Symptoms Compared With Patient-Report. Medical Care. 39(4). 397–408. 89 indexed citations
13.
Justice, Amy C., William C. Holmes, Allen L. Gifford, et al.. (2001). Development and validation of a self-completed HIV symptom index. Journal of Clinical Epidemiology. 54(12). S77–S90. 360 indexed citations
15.
Fichtenbaum, Carl J., Robert Zackin, Natasa Rajicic, et al.. (2000). Amphotericin B oral suspension for fluconazole-refractory oral candidiasis in persons with HIV infection. AIDS. 14(7). 845–852. 19 indexed citations
16.
Fichtenbaum, Carl J., Robert Zackin, Judith Feinberg, Constance A. Benson, & Jeffrey K. Griffiths. (2000). Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection. AIDS. 14(18). 2889–2893. 34 indexed citations
17.
Zackin, Robert, Rebecca A. Clark, Judith S. Currier, & Donna Mildvan. (1999). Predictive Markers of HIV-Related Weight Loss and Determination of Differences Between Populations With Weight Loss Stratified by Opportunistic Processes. JAIDS Journal of Acquired Immune Deficiency Syndromes. 22(2). 189–189. 7 indexed citations
18.
Zackin, Robert, Ian C. Marschner, Mary Kathryn Cowles, et al.. (1998). Perspective: Human Immunodeficiency Virus Type 1 (HIV‐1) RNA End Points in HIV Clinical Trials: Issues in Interim Monitoring and Early Stopping. The Journal of Infectious Diseases. 177(3). 761–765. 9 indexed citations
19.
Cohen, Cyrille J., James Hellinger, John Day, et al.. (1996). Lack of Effect of Cimetidine on Lymphocyte Subsets in Patients Infected with Human Immunodeficiency Virus Type 1. Clinical Infectious Diseases. 23(5). 1049–1054. 1 indexed citations
20.
Gottlieb, Michael S., Robert Zackin, Milan Fiala, et al.. (1991). Response to Treatment with the Leukocyte-derived Immunomodulator IMREG-1 in Immunocompromised Patients with AIDS-related Complex. Annals of Internal Medicine. 115(2). 84–91. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026